Studying Neuroendocrine Transdifferentiation as a Mechanism of Drug Resistance

Time: 1:30 pm
day: Day Two

Details:

  • How do mutiple tumors acquire resistance to targeted therapeutics by transdifferentiation?
  • Understanding if there is a common epigenetic state in the resulting neuroendocrine tumor type
  • Exploring how intratumoral heterogeneity is detected in these tumors

Speakers: